Improvement of blood pressure control in hypertensive patients with renal diseases

Yuko Ohta, Kazuhiko Tsuruya, Koji Fujii, Masanori Tokumoto, Hidetoshi Kanai, Kiyoshi Matsumura, Takuya Tsuchihashi, Hideki Hirakata, Mitsuo Iida

研究成果: ジャーナルへの寄稿記事

2 引用 (Scopus)

抄録

For hypertensive patients with renal diseases (RD), strict blood pressure (BP) control has been recommended in recent hypertension guidelines, such as JNC VI, JNC 7, WHO/ISH 1999 and ESH-ESC 2003. We assessed the current status of BP control and the changes of BP control before and after the publication of these guidelines in 489 hypertensive patients with or without RD (age, 19-89 years, mean 59±13 years) who visited the hypertension and kidney outpatient clinic at Kyushu University Hospital. The clinical characteristics of RD and non-RD patients were assessed (RD patients: age, 20-89 years, mean 60±13 years, n=311; non-RD patients: age, 19-86 years, mean 58±13 years, n=178). In addition, we compared the BP control status in 2003 to that in 1996. In 2003, the BP in RD patients was 134±16/78±10 mmHg and that in non-RD patients was 138±12/83±9 mmHg. When strict BP control was defined as <130/80 mmHg, the frequency of strict BP control in RD patients was 28.9% in 2003. In addition, the BP levels of RD patients in 2003 were significantly lower than those in 1996 (134±16/78±10 mmHg vs. 141±17/85±10 mmHg, p<0.05 for both systolic blood pressure [SBP] and diastolic blood pressure [DBP]), and the frequency of strict BP control in RD patients was higher in 2003 than in 1996 (28.9% vs. 11.8%, p<0.01). The BP levels of non-RD patients in 2003 tended to be lower than those in 1996 (138±12/83±9 mmHg vs. 141±13/85±9 mmHg, n.s.). In 2003, angiotensin II receptor blockers (ARBs) were more frequently prescribed to RD patients than to non-RD patients. Furthermore, the use of ARBs was markedly increased in 2003 compared with 1996. In conclusion, in our outpatient clinic, BP levels in hypertensive patients with RD have improved in recent years, and were lower than those in hypertensive patients without RD, which may in part reflect the physicians' awareness of the importance of strict BP control in RD patients, as suggested by several recent hypertension guidelines.

元の言語英語
ページ(範囲)295-300
ページ数6
ジャーナルHypertension Research
30
発行部数4
DOI
出版物ステータス出版済み - 4 1 2007

Fingerprint

Blood Pressure
Kidney
Angiotensin Receptor Antagonists
Guidelines
Ambulatory Care Facilities
Hypertension
Publications
Physicians

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

これを引用

Ohta, Y., Tsuruya, K., Fujii, K., Tokumoto, M., Kanai, H., Matsumura, K., ... Iida, M. (2007). Improvement of blood pressure control in hypertensive patients with renal diseases. Hypertension Research, 30(4), 295-300. https://doi.org/10.1291/hypres.30.295

Improvement of blood pressure control in hypertensive patients with renal diseases. / Ohta, Yuko; Tsuruya, Kazuhiko; Fujii, Koji; Tokumoto, Masanori; Kanai, Hidetoshi; Matsumura, Kiyoshi; Tsuchihashi, Takuya; Hirakata, Hideki; Iida, Mitsuo.

:: Hypertension Research, 巻 30, 番号 4, 01.04.2007, p. 295-300.

研究成果: ジャーナルへの寄稿記事

Ohta, Y, Tsuruya, K, Fujii, K, Tokumoto, M, Kanai, H, Matsumura, K, Tsuchihashi, T, Hirakata, H & Iida, M 2007, 'Improvement of blood pressure control in hypertensive patients with renal diseases', Hypertension Research, 巻. 30, 番号 4, pp. 295-300. https://doi.org/10.1291/hypres.30.295
Ohta Y, Tsuruya K, Fujii K, Tokumoto M, Kanai H, Matsumura K その他. Improvement of blood pressure control in hypertensive patients with renal diseases. Hypertension Research. 2007 4 1;30(4):295-300. https://doi.org/10.1291/hypres.30.295
Ohta, Yuko ; Tsuruya, Kazuhiko ; Fujii, Koji ; Tokumoto, Masanori ; Kanai, Hidetoshi ; Matsumura, Kiyoshi ; Tsuchihashi, Takuya ; Hirakata, Hideki ; Iida, Mitsuo. / Improvement of blood pressure control in hypertensive patients with renal diseases. :: Hypertension Research. 2007 ; 巻 30, 番号 4. pp. 295-300.
@article{1184cd0eb7fb415da64f74c792702bb2,
title = "Improvement of blood pressure control in hypertensive patients with renal diseases",
abstract = "For hypertensive patients with renal diseases (RD), strict blood pressure (BP) control has been recommended in recent hypertension guidelines, such as JNC VI, JNC 7, WHO/ISH 1999 and ESH-ESC 2003. We assessed the current status of BP control and the changes of BP control before and after the publication of these guidelines in 489 hypertensive patients with or without RD (age, 19-89 years, mean 59±13 years) who visited the hypertension and kidney outpatient clinic at Kyushu University Hospital. The clinical characteristics of RD and non-RD patients were assessed (RD patients: age, 20-89 years, mean 60±13 years, n=311; non-RD patients: age, 19-86 years, mean 58±13 years, n=178). In addition, we compared the BP control status in 2003 to that in 1996. In 2003, the BP in RD patients was 134±16/78±10 mmHg and that in non-RD patients was 138±12/83±9 mmHg. When strict BP control was defined as <130/80 mmHg, the frequency of strict BP control in RD patients was 28.9{\%} in 2003. In addition, the BP levels of RD patients in 2003 were significantly lower than those in 1996 (134±16/78±10 mmHg vs. 141±17/85±10 mmHg, p<0.05 for both systolic blood pressure [SBP] and diastolic blood pressure [DBP]), and the frequency of strict BP control in RD patients was higher in 2003 than in 1996 (28.9{\%} vs. 11.8{\%}, p<0.01). The BP levels of non-RD patients in 2003 tended to be lower than those in 1996 (138±12/83±9 mmHg vs. 141±13/85±9 mmHg, n.s.). In 2003, angiotensin II receptor blockers (ARBs) were more frequently prescribed to RD patients than to non-RD patients. Furthermore, the use of ARBs was markedly increased in 2003 compared with 1996. In conclusion, in our outpatient clinic, BP levels in hypertensive patients with RD have improved in recent years, and were lower than those in hypertensive patients without RD, which may in part reflect the physicians' awareness of the importance of strict BP control in RD patients, as suggested by several recent hypertension guidelines.",
author = "Yuko Ohta and Kazuhiko Tsuruya and Koji Fujii and Masanori Tokumoto and Hidetoshi Kanai and Kiyoshi Matsumura and Takuya Tsuchihashi and Hideki Hirakata and Mitsuo Iida",
year = "2007",
month = "4",
day = "1",
doi = "10.1291/hypres.30.295",
language = "English",
volume = "30",
pages = "295--300",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Improvement of blood pressure control in hypertensive patients with renal diseases

AU - Ohta, Yuko

AU - Tsuruya, Kazuhiko

AU - Fujii, Koji

AU - Tokumoto, Masanori

AU - Kanai, Hidetoshi

AU - Matsumura, Kiyoshi

AU - Tsuchihashi, Takuya

AU - Hirakata, Hideki

AU - Iida, Mitsuo

PY - 2007/4/1

Y1 - 2007/4/1

N2 - For hypertensive patients with renal diseases (RD), strict blood pressure (BP) control has been recommended in recent hypertension guidelines, such as JNC VI, JNC 7, WHO/ISH 1999 and ESH-ESC 2003. We assessed the current status of BP control and the changes of BP control before and after the publication of these guidelines in 489 hypertensive patients with or without RD (age, 19-89 years, mean 59±13 years) who visited the hypertension and kidney outpatient clinic at Kyushu University Hospital. The clinical characteristics of RD and non-RD patients were assessed (RD patients: age, 20-89 years, mean 60±13 years, n=311; non-RD patients: age, 19-86 years, mean 58±13 years, n=178). In addition, we compared the BP control status in 2003 to that in 1996. In 2003, the BP in RD patients was 134±16/78±10 mmHg and that in non-RD patients was 138±12/83±9 mmHg. When strict BP control was defined as <130/80 mmHg, the frequency of strict BP control in RD patients was 28.9% in 2003. In addition, the BP levels of RD patients in 2003 were significantly lower than those in 1996 (134±16/78±10 mmHg vs. 141±17/85±10 mmHg, p<0.05 for both systolic blood pressure [SBP] and diastolic blood pressure [DBP]), and the frequency of strict BP control in RD patients was higher in 2003 than in 1996 (28.9% vs. 11.8%, p<0.01). The BP levels of non-RD patients in 2003 tended to be lower than those in 1996 (138±12/83±9 mmHg vs. 141±13/85±9 mmHg, n.s.). In 2003, angiotensin II receptor blockers (ARBs) were more frequently prescribed to RD patients than to non-RD patients. Furthermore, the use of ARBs was markedly increased in 2003 compared with 1996. In conclusion, in our outpatient clinic, BP levels in hypertensive patients with RD have improved in recent years, and were lower than those in hypertensive patients without RD, which may in part reflect the physicians' awareness of the importance of strict BP control in RD patients, as suggested by several recent hypertension guidelines.

AB - For hypertensive patients with renal diseases (RD), strict blood pressure (BP) control has been recommended in recent hypertension guidelines, such as JNC VI, JNC 7, WHO/ISH 1999 and ESH-ESC 2003. We assessed the current status of BP control and the changes of BP control before and after the publication of these guidelines in 489 hypertensive patients with or without RD (age, 19-89 years, mean 59±13 years) who visited the hypertension and kidney outpatient clinic at Kyushu University Hospital. The clinical characteristics of RD and non-RD patients were assessed (RD patients: age, 20-89 years, mean 60±13 years, n=311; non-RD patients: age, 19-86 years, mean 58±13 years, n=178). In addition, we compared the BP control status in 2003 to that in 1996. In 2003, the BP in RD patients was 134±16/78±10 mmHg and that in non-RD patients was 138±12/83±9 mmHg. When strict BP control was defined as <130/80 mmHg, the frequency of strict BP control in RD patients was 28.9% in 2003. In addition, the BP levels of RD patients in 2003 were significantly lower than those in 1996 (134±16/78±10 mmHg vs. 141±17/85±10 mmHg, p<0.05 for both systolic blood pressure [SBP] and diastolic blood pressure [DBP]), and the frequency of strict BP control in RD patients was higher in 2003 than in 1996 (28.9% vs. 11.8%, p<0.01). The BP levels of non-RD patients in 2003 tended to be lower than those in 1996 (138±12/83±9 mmHg vs. 141±13/85±9 mmHg, n.s.). In 2003, angiotensin II receptor blockers (ARBs) were more frequently prescribed to RD patients than to non-RD patients. Furthermore, the use of ARBs was markedly increased in 2003 compared with 1996. In conclusion, in our outpatient clinic, BP levels in hypertensive patients with RD have improved in recent years, and were lower than those in hypertensive patients without RD, which may in part reflect the physicians' awareness of the importance of strict BP control in RD patients, as suggested by several recent hypertension guidelines.

UR - http://www.scopus.com/inward/record.url?scp=34249056172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249056172&partnerID=8YFLogxK

U2 - 10.1291/hypres.30.295

DO - 10.1291/hypres.30.295

M3 - Article

C2 - 17541207

AN - SCOPUS:34249056172

VL - 30

SP - 295

EP - 300

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 4

ER -